Clinical Trials Logo

Perianal Warts clinical trials

View clinical trials related to Perianal Warts.

Filter by:
  • None
  • Page 1

NCT ID: NCT03038828 Terminated - Perianal Warts Clinical Trials

Study of Leukocyte Interleukin, Injection for Treatment of Perianal Warts

PAW
Start date: April 2015
Phase: Phase 1
Study type: Interventional

Study is a dose escalation study. Fifteen patients will be enrolled in 2 treatment cohorts. Five participants (cohort A) will be treated with 200IU Multikine daily, 5 days/week for 2 weeks, off 2 weeks, then again 5 days/week for 2 weeks. If no serious adverse events are noted in cohort A patients, ten participants will be treated in cohort B. Cohort B participants will be treated the same as cohort A participants except that dose will be increased to 400IU Multikine per day.

NCT ID: NCT02462187 Completed - Genital Warts Clinical Trials

Topical NVN1000 for the Treatment of External Genital and Perianal Warts

Start date: June 12, 2015
Phase: Phase 2
Study type: Interventional

A Phase 2 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Ascending Dose Study Assessing Tolerability, Safety, and Efficacy of Topical NVN1000 in Subjects with External Genital Warts and Perianal Warts

NCT ID: NCT01082302 Completed - Genital Warts Clinical Trials

Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage

Start date: January 2010
Phase: Phase 4
Study type: Interventional

This open, monocentric study is designed to investigate plasma concentrations of certain catechins after topical application of Veregen 15% ointment to genital or perianal warts in comparison to catechin plasma concentrations after oral intake of a defined dose of green tea beverage. The study is intended to demonstrate that topical administration of Veregen 15% induces catechin plasma concentrations lower or equivalent to those that can be reached with normal consumption of green tea.